Current and Future PET imaging for multiple myeloma
M Ishibashi, M Takahashi, T Yamaya, Y Imai - Life, 2023 - mdpi.com
Positron emission tomography (PET) is an imaging modality used for the noninvasive
assessment of tumor staging and response to therapy. PET with 18F labeled …
assessment of tumor staging and response to therapy. PET with 18F labeled …
First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
R Laforest, A Ghai, TJ Fraum, R Oyama… - Journal of Nuclear …, 2023 - Soc Nuclear Med
There remains an unmet need for molecularly targeted imaging agents for multiple myeloma
(MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM …
(MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM …
Comparison of a Series of 68Ga-Labeled DOTA-LLP2A Conjugates for Positron Emission Tomography Imaging of Very Late Antigen-4 in Melanoma
P Zhou, Y Wu, G Han, J Jiang, H Wang… - Molecular …, 2025 - ACS Publications
Melanoma, with its steadily rising global incidence, is characterized by high invasiveness,
leading to poor prognosis in advanced stages. There remains an unmet clinical need for the …
leading to poor prognosis in advanced stages. There remains an unmet clinical need for the …
Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for Melanoma
MD Pun, F Gallazzi, KV Ho, L Watkinson… - Molecular …, 2024 - ACS Publications
Very late antigen-4 (VLA-4) is a transmembrane integrin protein that is highly expressed in
aggressive forms of metastatic melanoma. A small-molecule peptidomimetic, LLP2A, was …
aggressive forms of metastatic melanoma. A small-molecule peptidomimetic, LLP2A, was …
Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific 89Zr-Labeled Natalizumab Immuno-Positron Emission Tomography
M Kim, KH Jung, JL Kim, HJ Koo, HJ Jung… - Molecular …, 2024 - ACS Publications
Very late antigen-4 (VLA4; CD49d) is a promising immune therapy target in treatment-
resistant leukemia and multiple myeloma, and there is growing interest in repurposing the …
resistant leukemia and multiple myeloma, and there is growing interest in repurposing the …
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
ABSTRACT The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma
Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on …
Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on …
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
Abstract The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma
Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on …
Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on …